Polycystic ovarian syndrome: affecting quality of life and awaiting cure
DOI:
https://doi.org/10.18203/2320-6012.ijrms20254105Keywords:
Polycystic ovarian syndrome, BMI, Hyperandrogenism, Oligo/anovulation, HirsutismAbstract
Background: The increasing number of polycystic ovarian syndrome (PCOS) patients in gynaecology outdoor especially younger adults, with long term health implications prompts us to study the condition. The syndrome not only has a vast impact on physical health but also affects psychosocial aspects of life. The study aimed to analyse the characteristics and presenting complaints in subjects with PCOS.
Methods: It was an observational study conducted at a secondary care centre over a period of one year. Chi square goodness of fit test was used to analyse the results.
Results: The study showed an increased incidence in younger adults with menstrual irregularity as the most common complaint and an increased body mass index (BMI) amongst most patients. Inability to conceive without treatment was also very important presenting feature.
Conclusions: We should increase our efforts to find a preventive strategy and if possible, a cure to this syndrome.
Metrics
References
Bozdag G, Mumusoglu S, Zengin D, Karabulut E, Yildiz BO. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841-55. DOI: https://doi.org/10.1093/humrep/dew218
Mousa A, Tay CT, Teede H. Technical Report for the 2023 International Evidence based guideline for the assessment and management of polycystic ovarian syndrome. Monash University. 2023.
Andhalkar S, Chaware V, Redasani V. A Review on Medicinal Plants of Natural Origin for Treatment of Polycystic Ovarian Syndrome (PCOS). Asian J Pharmaceut Res Develop. 2021;9(3):76-81. DOI: https://doi.org/10.22270/ajprd.v9i3.949
Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487-525. DOI: https://doi.org/10.1210/er.2015-1018
Christ JP, Cedars MI. Current Guidelines for Diagnosing PCOS. Diagnostics (Basel). 2023;13(6):1113. DOI: https://doi.org/10.3390/diagnostics13061113
Ikeda K, Baba T, Morishita M, Honnma H, Endo T, Kiya T, et al. Long-term treatment with dehydroepiandrosterone may lead to follicular atresia through interaction with anti-Mullerian hormone. J Ovarian Res. 2014;7:46. DOI: https://doi.org/10.1186/1757-2215-7-46
Agarwal M, Sinha S, Lohani P, Singh R, Dureja S. Polycystic Ovarian Syndrome in Aging Women: An Observational Study. Cureus. 2022;14(9):e29776. DOI: https://doi.org/10.7759/cureus.29776
Echiburú B, Pérez-Bravo F, Galgani JE, Sandoval D, Saldías C, Crisosto N, et al. Enlarged adipocytes in subcutaneous adipose tissue associated to hyperandrogenism and visceral adipose tissue volume in women with polycystic ovary syndrome. Steroids. 2018;130:15-21. DOI: https://doi.org/10.1016/j.steroids.2017.12.009
Mirmasoumi G, Fazilati M, Foroozanfard F, Vahedpoor Z, Mahmoodi S, Taghizadeh M, et al. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Exp Clin Endocrinol Diabetes. 2018;126(4):222-8. DOI: https://doi.org/10.1055/a-1736-9017
Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 International Evidence Based guideline for the Assessment and Management of Polycystic Ovarian Syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-69. DOI: https://doi.org/10.1210/clinem/dgad463
Shi D, Vine DF. Animal models of polycystic ovary syndrome: a focused review of rodent models in relationship to clinical phenotypes and cardiometabolic risk. Alberta Institute for Human Nutrition, Metabolic and Cardiovascular Disease Laboratory, University of Alberta, Edmonton, Alberta, Canada. 2009.
Spritzer PM. Polycystic ovary syndrome: Reviewing diagnosis and management of metabolic disturbances. Arq Bras Endocrinol Metabol. 2014;58(2):182-7. DOI: https://doi.org/10.1590/0004-2730000003051
Downloads
Published
How to Cite
Issue
Section
